Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNAs as Regulators of Cisplatin Resistance in Lung Cancer

1 Jan 2015

Abstract excerpt

Cisplatin (CDDP) is one of the most effective broad-spectrum anticancer drugs, which has been employed for the treatment of lung cancer. The development of CDDP resistance is a major problem of tumor chemotherapy. MicroRNAs (miRNAs) are an abundant class of small non-protein-coding RNAs, involved in the initiation and progression of human cancer. Increasing evidence has shown that dysregulation of miRNAs is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Lung Cancer Research Studies
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26584286
DOI: 10.1159/000438548

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNAs as Regulators of Cisplatin Resistance in Lung CancerPMID 26584286Read ↗

MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to CisplatinSemantic proximity Read ↗

The role of microRNA in cisplatin resistance or sensitivitySemantic proximity Read ↗

Regulation of cisplatin resistance in lung cancer by epigenetic mechanismsSemantic proximity Read ↗

Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung CancerSemantic proximity Read ↗

MicroRNAs as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells.Semantic proximity Read ↗

MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2.Semantic proximity Read ↗

Role of microRNAs in chemoresistance.Semantic proximity Read ↗

MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: A comprehensive analysis based on microarray dataSemantic proximity Read ↗

MicroRNAs as the critical regulators of autophagy-mediated cisplatin response in tumor cellsSemantic proximity Read ↗

Critical microRNAs in Lung Cancer: Recent Advances and Potential ApplicationsSemantic proximity Read ↗

The regulatory role of autophagy-related miRNAs in lung cancer drug resistanceSemantic proximity Read ↗

Long Noncoding RNAs as Biotargets in Cisplatin-Based Drug ResistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.